State TX
Clinical Trials in Texas
Recruiting clinical trials with at least one study location in Texas. Data updated daily from ClinicalTrials.gov.
Top Conditions in Texas
Frequently Asked Questions — Clinical Trials in Texas
How many clinical trials are currently recruiting in Texas?
ClinicalMetric currently tracks 736 actively recruiting clinical trials with at least one location in Texas. The total number of registered studies—including active but not currently enrolling trials—is 736. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Texas?
Texas hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Prostate Cancer, Colorectal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Texas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Texas?
To join a clinical trial in Texas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Texas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Texas
NCT05490225 N/A
Recruiting
Access Cannulation Trial II
Condition
Dialysis; Complications
Enrollment
100 pts
Location
United States
Sponsor
Voyager Biomedical
NCT02915198 Phase 4
Recruiting
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuT...
Condition
Prediabetic State
Enrollment
7,410 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT07490184 N/A
Recruiting
Cardiac Clearance vs G60 Hip Frailty Index
Condition
Cardiac Disease
Enrollment
100 pts
Location
United States
Sponsor
Methodist Health System
NCT05201781 Phase 4
Recruiting
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autole...
Condition
Multiple Myeloma
Enrollment
295 pts
Location
United States, Belgium, China
Sponsor
Janssen Research & Development
NCT07228117 N/A
Recruiting
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adult...
Condition
Type 1 Diabetes Mellitus
Enrollment
400 pts
Location
United States, Australia, New Zealand
Sponsor
Medtronic MiniMed, Inc.
NCT06516952 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participant...
Condition
Prurigo Nodularis
Enrollment
330 pts
Location
United States, Argentina, Austria
Sponsor
Incyte Corporation
NCT06433752 N/A
Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMV...
Condition
Relapsing Multiple Sclerosis
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
TG Therapeutics, Inc.
NCT07115940 N/A
Recruiting
Medical Management With Endovascular Thrombectomy Versus Medical Management Alon...
Condition
Acute Ischemic Stroke
Enrollment
408 pts
Location
United States
Sponsor
Amrou Sarraj
NCT05787821 N/A
Recruiting
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Condition
Knee Pain Chronic
Enrollment
760 pts
Location
United States
Sponsor
Zimmer Biomet
NCT06629584 Phase 2
Recruiting
Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic M...
Condition
Malignant Solid Tumors
Enrollment
40 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06982352 Phase 1
Recruiting
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
Condition
Atopic Dermatitis (AD)
Enrollment
48 pts
Location
United States, Jordan
Sponsor
LAPIX Therapeutics Inc.
NCT06421558 N/A
Recruiting
Impact of Direct Current Electrical Stimulation on Treatment of Lumbosacral Radi...
Condition
Radiculopathy Lumbar
Enrollment
150 pts
Location
United States
Sponsor
NeuFit - Neurological Fitness
NCT06667908 Phase 2
Recruiting
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolida...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
130 pts
Location
United States, Australia, Brazil
Sponsor
Johnson & Johnson Enterprise I
NCT05719558 Phase 1
Recruiting
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
210 pts
Location
United States
Sponsor
Astellas Pharma Global Develop
NCT04661358 Phase 3
Recruiting
Fenofibrate for Prevention of DR Worsening
Condition
Diabetic Retinopathy
Enrollment
560 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
NCT06249555 N/A
Recruiting
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With C...
Condition
Crohn's Disease
Enrollment
300 pts
Location
United States, Canada
Sponsor
Alimentiv Inc.
NCT06507878 N/A
Recruiting
Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of C...
Condition
Thyroid Cancer
Enrollment
459 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT03971487 Phase 1, Phase 2
Recruiting
Ocrelizumab for Psychosis by Autoimmunity
Condition
Schizo-Affective Type of Psychosis
Enrollment
40 pts
Location
United States
Sponsor
The Methodist Hospital Researc
NCT04177914 Phase 3
Recruiting
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Condition
Hydrocephalus
Enrollment
176 pts
Location
United States, Canada
Sponsor
University of Utah
NCT06002633 N/A
Recruiting
Approach-Avoidance and Alcohol Challenge Study in PTSD
Condition
Post-Traumatic Stress Disorder
Enrollment
200 pts
Location
United States
Sponsor
University of Texas at Austin
NCT06115252 N/A
Recruiting
Partnering to Enhance Emerging Adults' Response to Programs
Condition
Alcohol Use, Unspecified
Enrollment
248 pts
Location
United States
Sponsor
UConn Health
NCT01356290 Phase 2
Recruiting
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ...
Condition
Medulloblastoma Recurrent
Enrollment
232 pts
Location
United States, Austria, Czechia
Sponsor
Medical University of Vienna
NCT04615013 Phase 1
Recruiting
NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Canc...
Condition
Cervical Esophagus Adenocarcinoma
Enrollment
24 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT07102160 N/A
Recruiting
Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtend...
Condition
Deep Vein Thrombosis (DVT)
Enrollment
185 pts
Location
United States
Sponsor
Argon Medical Devices
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology